Bills · HR 6664
IN COMMITTEE· 119TH CONGRESS
House BillHR 6664Armed Forces and National Security
To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.
INTRO DEC 11· LAST ACTION DEC 11
READING
3MIN
COSPONSORS
0
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it aims to strengthen the U.S. military's ability to leverage cutting-edge biotechnology, which is increasingly vital for national security and defense. By establishing a dedicated office, the Pentagon can create a more focused and coordinated approach to developing and integrating new biotech capabilities, from advanced materials to biodefense solutions. If this bill becomes law, it could accelerate innovation in bioindustrial manufacturing within the U.S., potentially reducing the military's reliance on foreign supply chains for critical components and fostering a robust domestic biotech defense industry. Without it, the DoD's biotechnology efforts might remain fragmented, potentially slowing down the adoption of new technologies and making it harder for the U.S. to maintain its competitive edge in this rapidly advancing field.
KEY PROVISIONS
5AI-extractedPROVISION 01
Establishes a Biotechnology Management Office (BMO) within the Department of Defense to manage biotechnology issues.
This creates a dedicated organizational structure to centralize and coordinate the military's biotechnology efforts.
PROVISION 02
Designates a senior official within the Department of Defense with relevant biotechnology experience to lead the BMO.
Ensures high-level expertise and leadership are specifically focused on integrating biotechnology into defense strategies.
PROVISION 03
Directs the BMO to maintain a long-term research roadmap, update policies for acquiring biotech products, and coordinate with various external partners.
Aims to streamline the development-to-deployment process for new biotech capabilities and foster collaborative innovation.
PROVISION 04
Clarifies that existing Department of Defense research, development, test, and evaluation funds can be used for the design and construction of bioindustrial manufacturing processes.
Provides specific funding flexibility to build the necessary infrastructure for producing bio-based products for defense purposes.
PROVISION 05
The entire section establishing the Biotechnology Management Office and its responsibilities will terminate on September 30, 2030.
Sets a specific expiration date for the office, allowing for a future re-evaluation of its effectiveness and continued need.
SPONSORSHIP
1 + 0
D· Colorado
YRS IN OFFICE
7
BILLS LED
92
ACTION TIMELINE
2 EVENTSDEC 11
Introduced in House
DEC 11
Referred to the House Committee on Armed Services.
BILL INFO
TypeHouse Bill
NumberHR 6664
Congress119th
StatusIn Committee
IntroducedDec 11, 2025
Last actionDec 11, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ARMED SERVICES COMMITTEE · INTRODUCED DEC 11, 2025
House BillHR 6664Armed Forces and National Security
To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.
INTRODUCED DEC 11, 2025· LAST ACTION DEC 11, 2025
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
0
COMPLEXITY
Moderate
